Proteomics International Laboratories Ltd (PIQ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Proteomics International Laboratories Ltd (PIQ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7903
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteomics International Laboratories Ltd (Proteomics International) is a medical technology company that discovers new biopharmaceutical drugs. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and drug discovery. Proteomics International developed PromarkerD, a predictive test for the diagnosis of diabetic kidney disease. Its analytical services include pharmacokinetic testing, biosimilars or biologic drug characterization, and proteome mapping. The company works on the discovery of painkillers and antibiotics drug compounds from animal venom. It serves the pharmaceutical industry across Australia. Proteomics International is headquartered in Nedlands, Western Australia, Australia.

Proteomics International Laboratories Ltd (PIQ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Proteomics International Laboratories Ltd, Medical Equipment, Deal Details 10
Partnerships 10
PrismHealthDx Enters into Licensing Agreement with Proteomics International Labs 10
Proteomics International and Atturos Enter into Co-Development Agreement 11
Equity Offering 12
Proteomics International Raises USD0.4 Million in Share Purchase Plan 12
Proteomics International Raises USD1.1 Million in Private Placement of Shares 13
Proteomics International Laboratories Raises USD2.4 Million in Initial Public Offering of Common Stock 14
Acquisition 15
Proteomics International to Sell Stake in CPR Pharma Services 15
Proteomics International Laboratories Ltd – Key Competitors 16
Proteomics International Laboratories Ltd – Key Employees 17
Proteomics International Laboratories Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Nov 22, 2017: Proteomics International strengthens Board and Business Development team 19
Legal and Regulatory 20
May 09, 2017: Proteomics International becomes world’s most accredited protein testing laboratory, launches pharmacokinetic and companion diagnostic testing for clinical trials 20
Other Significant Developments 21
Jan 25, 2018: Proteomics International Laboratories: Quarterly Business Update 21
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Proteomics International Laboratories Ltd, Medical Equipment, Key Facts, 2018 2
Proteomics International Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Deals By Market, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PrismHealthDx Enters into Licensing Agreement with Proteomics International Labs 10
Proteomics International and Atturos Enter into Co-Development Agreement 11
Proteomics International Raises USD0.4 Million in Share Purchase Plan 12
Proteomics International Raises USD1.1 Million in Private Placement of Shares 13
Proteomics International Laboratories Raises USD2.4 Million in Initial Public Offering of Common Stock 14
Proteomics International to Sell Stake in CPR Pharma Services 15
Proteomics International Laboratories Ltd, Key Competitors 16
Proteomics International Laboratories Ltd, Key Employees 17
Proteomics International Laboratories Ltd, Other Locations 18

List of Figures
Proteomics International Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Proteomics International Laboratories Ltd (PIQ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CNX Resources Corp (CNX):企業の財務・戦略的SWOT分析
    CNX Resources Corp (CNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Humanwell Healthcare (Group) Co Ltd (600079):製薬・医療:M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • American Financial Group, Inc.:企業のM&A・事業提携・投資動向
    American Financial Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American Financial Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Eisai Co., Ltd.:企業のM&A・事業提携・投資動向
    Eisai Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eisai Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Johnson & Johnson Vision Care Inc:医療機器:M&Aディール及び事業提携情報
    Summary Johnson & Johnson Vision Care Inc (J&J Vision Care), a subsidiary of Johnson & Johnson, is a medical device company that manufactures and markets contact lens and spectacle products. The company offers products such as disposable contact lens; contact lenses with astigmatism; contact lenses …
  • Clean Energy Fuels Corp (CLNE):企業の財務・戦略的SWOT分析
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Babcock International Group Plc:企業のM&A・事業提携・投資動向
    Babcock International Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Babcock International Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Atmos Energy Corp (ATO):企業の財務・戦略的SWOT分析
    Atmos Energy Corp (ATO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • NN Group NV:企業の戦略・SWOT・財務情報
    NN Group NV - Strategy, SWOT and Corporate Finance Report Summary NN Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • MeVis Medical Solutions AG (M3V):企業の財務・戦略的SWOT分析
    MeVis Medical Solutions AG (M3V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務情報
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Diamondback Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Diamondback Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Diamondback Energy Inc (Diamondback Energy) is an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, on …
  • Quantum Fuel Systems LLC (QTWWQ):企業の戦略的SWOT分析
    Quantum Fuel Systems LLC (QTWWQ) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Crown Point Energy Inc (CWV):石油・ガス:M&Aディール及び事業提携情報
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • Sebia SA:製品パイプライン分析
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers for diagnosis of cancer. The company's electrophoresis program offer automated system for capillary electrophoresis, gel electrophoresis and electrophoresi …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Skandinaviska Enskilda Banken AB:企業の戦略・SWOT・財務分析
    Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report Summary Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆